|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
doi: 10.1242/10.1242/dev.00530
1 Shriners Hospital for Children, Portland, OR 97239, USA
2 Oregon Health and Sciences University, Department of Molecular and Medical
Genetics, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
* Author for correspondence (e-mail: hss{at}shcc.org)
Accepted 8 April 2003
In humans and mice, mutations in Hoxa13 cause malformation of limb and genitourinary (GU) regions. In males, one of the most common GU malformations associated with loss of Hoxa13 function is hypospadia, a condition defined by the poor growth and closure of the urethra and glans penis. By examining early signaling in the developing mouse genital tubercle, we show that Hoxa13 is essential for normal expression of Fgf8 and Bmp7 in the urethral plate epithelium. In Hoxa13GFP-mutant mice, hypospadias occur as a result of the combined loss of Fgf8 and Bmp7 expression in the urethral plate epithelium, as well as the ectopic expression of noggin (Nog) in the flanking mesenchyme. In vitro supplementation with Fgf8 restored proliferation in homozygous mutants to wild-type levels, suggesting that Fgf8 is sufficient to direct early proliferation of the developing genital tubercle. However, the closure defects of the distal urethra and glans can be attributed to a loss of apoptosis in the urethra, which is consistent with reduced Bmp7 expression in this region. Mice mutant for Hoxa13 also exhibit changes in androgen receptor expression, providing a developmental link between Hoxa13-associated hypospadias and those produced by antagonists to androgen signaling. Finally, a novel role for Hoxa13 in the vascularization of the glans penis is also identified.
Key words: Hoxa13, Mouse, Genitourinary development, Hypospadia
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
S. Miyagawa, Y. Satoh, R. Haraguchi, K. Suzuki, T. Iguchi, M. M. Taketo, N. Nakagata, T. Matsumoto, K.-i. Takeyama, S. Kato, et al. Genetic Interactions of the Androgen and Wnt/{beta}-Catenin Pathways for the Masculinization of External Genitalia Mol. Endocrinol., June 1, 2009; 23(6): 871 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fantini, G. Vaccari, N. Brison, P. Debeer, P. Tylzanowski, and V. Zappavigna A G220V substitution within the N-terminal transcription regulating domain of HOXD13 causes a variant synpolydactyly phenotype Hum. Mol. Genet., March 1, 2009; 18(5): 847 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lin, Y. Yin, F. Long, and L. Ma Tissue-specific requirements of {beta}-catenin in external genitalia development Development, August 15, 2008; 135(16): 2815 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Beleza-Meireles, V. Tohonen, C. Soderhall, C. Schwentner, C. Radmayr, I. Kockum, and A. Nordenskjold Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias Eur. J. Endocrinol., May 1, 2008; 158(5): 729 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kohler, A.-L. Delezoide, B. Boizet-Bonhoure, M. J McPhaul, C. Sultan, and S. Lumbroso Coexpression of Wilms' tumor suppressor 1 (WT1) and androgen receptor (AR) in the genital tract of human male embryos and regulation of AR promoter activity by WT1 J. Mol. Endocrinol., May 1, 2007; 38(5): 547 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Knosp, C. Saneyoshi, S. Shou, H. P. Bachinger, and H. S. Stadler Elucidation, Quantitative Refinement, and in Vivo Utilization of the HOXA13 DNA Binding Site J. Biol. Chem., March 2, 2007; 282(9): 6843 - 6853. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Haraguchi, J. Motoyama, H. Sasaki, Y. Satoh, S. Miyagawa, N. Nakagata, A. Moon, and G. Yamada Molecular analysis of coordinated bladder and urogenital organ formation by Hedgehog signaling Development, February 1, 2007; 134(3): 525 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Salsi and V. Zappavigna Hoxd13 and Hoxa13 Directly Control the Expression of the EphA7 Ephrin Tyrosine Kinase Receptor in Developing Limbs J. Biol. Chem., January 27, 2006; 281(4): 1992 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. McCabe and J. W. Innis A genomic approach to the identification and characterization of HOXA13 functional binding elements Nucleic Acids Res., November 30, 2005; 33(21): 6782 - 6794. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rey, E. Codner, G. Iniguez, P. Bedecarras, R. Trigo, C. Okuma, S. Gottlieb, I. Bergada, S. M. Campo, and F. G. Cassorla Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6035 - 6040. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Williams, M. E. Williams, J. H. Heaton, T. D. Gelehrter, and J. W. Innis Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability Nucleic Acids Res., August 8, 2005; 33(14): 4475 - 4484. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cobb and D. Duboule Comparative analysis of genes downstream of the Hoxd cluster in developing digits and external genitalia Development, July 1, 2005; 132(13): 3055 - 3067. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yamada Reproductive/Urogenital Organ Development and Molecular Genetic Cascades: Glamorous Developmental Processes of Bodies J. Biochem., June 1, 2005; 137(6): 665 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Scott, E. A. Morgan, and H. S. Stadler Genitourinary Functions of Hoxa13 and Hoxd13 J. Biochem., June 1, 2005; 137(6): 671 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Petiot, C. L. Perriton, C. Dickson, and M. J. Cohn Development of the mammalian urethra is controlled by Fgfr2-IIIb Development, May 15, 2005; 132(10): 2441 - 2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Innis, D. Mortlock, Z. Chen, M. Ludwig, M. E. Williams, T. M. Williams, C. D. Doyle, Z. Shao, M. Glynn, D. Mikulic, et al. Polyalanine expansion in HOXA13: three new affected families and the molecular consequences in a mouse model Hum. Mol. Genet., November 15, 2004; 13(22): 2841 - 2851. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Knosp, V. Scott, H. P. Bachinger, and H. S. Stadler HOXA13 regulates the expression of bone morphogenetic proteins 2 and 7 to control distal limb morphogenesis Development, September 15, 2004; 131(18): 4581 - 4592. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, D. Bachiller, Y. P. Chen, M. Kamikawa, H. Ogi, R. Haraguchi, Y. Ogino, Y. Minami, Y. Mishina, K. Ahn, et al. Regulation of outgrowth and apoptosis for the terminal appendage: external genitalia: development by concerted actions of BMP signaling Development, December 22, 2003; 130(25): 6209 - 6220. [Abstract] [Full Text] [PDF] |
||||